Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease  Nan Zhang, MD, PhD, Thibaut Van Zele, MD, PhD, Claudina.

Slides:



Advertisements
Similar presentations
Severe Chronic Upper Respiratory Disease: Phenotyping Inflammation
Advertisements

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Serum granzymes and CD30 are increased in children's milk protein sensitive enteropathy and celiac disease  Merja T. Augustin, MD, Jorma Kokkonen, MD,
Serum granzymes and CD30 are increased in children's milk protein sensitive enteropathy and celiac disease  Merja T. Augustin, MD, Jorma Kokkonen, MD,
Clarification concerning amoxicillin skin testing
Critical link between glycogen synthase kinase 3β and forkhead box P3 in patients with chronic rhinosinusitis with nasal polyps  Xingmei Wu, MD, Sihua.
Fatty acids, inflammation, and asthma
Chlamydophila (Chlamydia) pneumoniae serology and asthma in adults: A longitudinal analysis  Rafael Pasternack, MD, PhD, Heini Huhtala, MSc, Jussi Karjalainen,
Endotype-driven care pathways in patients with chronic rhinosinusitis
Obstructive sleep apnea syndrome and inflammation
Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois  Bruce K. Tan, MD, MS, Aiko I. Klingler, PhD,
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment  Junko Murata,
Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese  Ping-Ping Cao, MD, Hua-Bin Li, MD, PhD, Bao-Feng.
Oral steroids and doxycycline: Two different approaches to treat nasal polyps  Thibaut Van Zele, MD, PhD, Philippe Gevaert, MD, PhD, Gabriele Holtappels,
Is 9 more than 2 also in allergic airway inflammation?
Fatty acids, inflammation, and asthma
Heleen D. de Koning, MD, Joost Schalkwijk, PhD, Jos W. M
Evidence of a role for B cell–activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps  Atsushi Kato, PhD,
Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis  Philippe Gevaert, MD, PhD, Nicholas Van Bruaene, MD, Tom Cattaert,
T-cell regulation in chronic paranasal sinus disease
Staphylococcus aureus enhances the tight junction barrier integrity in healthy nasal tissue, but not in nasal polyps  Can Altunbulakli, MSc, Rita Costa,
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania  Xiangdong Wang, MD, PhD,
The National Biome Initiative: An allergy perspective
RAGE processing in chronic airway conditions: Involvement of Staphylococcus aureus and ECP  Koen Van Crombruggen, PhD, Gabriele Holtappels, Natalie De.
TH17 and TH22 cells: A confusion of antimicrobial response with tissue inflammation versus protection  Mübeccel Akdis, MD, PhD, Oscar Palomares, PhD,
Profiling of human CD4+ T-cell subsets identifies the TH2-specific noncoding RNA GATA3-AS1  Huan Zhang, MD, PhD, Colm E. Nestor, PhD, Shuli Zhao, PhD,
The quest for autoreactive antibodies in nasal polyps
TGF-β signaling and collagen deposition in chronic rhinosinusitis
Comparison of a new Skin Prick Test Tape with the conventional skin prick test  Zhengpeng Gong, MD, Zhijie Yang, PhD, Ran Wu, MD, Huiping Ye, MD, PhD,
The Editors' Choice Journal of Allergy and Clinical Immunology
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
The Editors' Choice Journal of Allergy and Clinical Immunology
The Editors' Choice Journal of Allergy and Clinical Immunology
Reduced placental FOXP3 associated with subsequent infant allergic disease  Susan L. Prescott, PhD, MD, Meri Tulic, PhD, Annette Osei-Kumah, PhD, Tara.
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Claus Bachert, MD, PhD, Cezmi A. Akdis, MD 
Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think  Martin L. Moore, PhD, R.
What is an “eosinophilic phenotype” of asthma?
Weiguo Chen, PhD, Gurjit K. Khurana Hershey, MD, PhD 
Cephalosporin Side Chain Cross-reactivity
Liam O’Mahony, PhD, Mübeccel Akdis, MD, PhD, Cezmi A. Akdis, MD 
IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis  Hyun-Woo Shin, MD, PhD, Dong-Kyu Kim, MD, Min-Hyun Park, MD,
Role of regulatory T cells and FOXP3 in human diseases
Autophagy: Nobel Prize 2016 and allergy and asthma research
IL-2– and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets  Sven Létourneau, DPhil, Carsten Krieg, PhD, Giuseppe Pantaleo,
Advances in the approach to the patient with food allergy
Allergic fungal rhinosinusitis—more than a fungal disease?
Lei Wang, MD, PhD, Jesse P. Joad, MD, Caiyun Zhong, MD, PhD, Kent E
Claus Bachert, MD, PhD, Luo Zhang, MD, Phillippe Gevaert, MD 
Biology of nasal polyposis
Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps  Joke Patou, MD, Philippe Gevaert, MD, PhD, Thibaut.
The Editors' Choice Journal of Allergy and Clinical Immunology
Macrolide antibiotics and asthma treatment
Asthma: The past, future, environment, and costs
Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania  Xiangdong Wang, MD, PhD,
Genetic regulation of IgE responses: Achilles and the tortoise
Interrupting IL-6–receptor signaling improves atopic dermatitis but associates with bacterial superinfection  Alexander A. Navarini, MD, PhD, Lars E.
Environmental factors and eosinophilic esophagitis
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Mite allergen–specific IgE is detectable in bronchial secretions of patients with nonatopic asthma and correlates with mucosal expression of periostin 
Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma  Philippe Gevaert, MD, PhD, Lien Calus, MD, Thibaut Van Zele,
Immunopathology of atopic dermatitis
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Itching as a systemic disease
Chitinases and chitinase-like proteins in TH2 inflammation and asthma
Presentation transcript:

Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease  Nan Zhang, MD, PhD, Thibaut Van Zele, MD, PhD, Claudina Perez-Novo, PhD, Nicholas Van Bruaene, MD, Gabriele Holtappels, Natalie DeRuyck, Paul Van Cauwenberge, MD, PhD, Claus Bachert, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 122, Issue 5, Pages 961-968 (November 2008) DOI: 10.1016/j.jaci.2008.07.008 Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Semiquantitative evaluation of granulocyte tissue infiltration. Values are reported as medians and interquartile ranges for each group. The significance level was set at an α value of .05. Concentrations for ECP and MPO are reported as medians and interquartile ranges for each group, and the significance level equals a P value of .05. From these data, an ECP/MPO ratio was calculated. HE, Hematoxylin. Journal of Allergy and Clinical Immunology 2008 122, 961-968DOI: (10.1016/j.jaci.2008.07.008) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 mRNA levels for T-bet, GATA-3, RORC, and Foxp3 transcription factors normalized to the levels of β-actin, hydroxymethylbilane synthase, and elongation factor 1 as housekeeping genes in each group. Values are reported as medians and interquartile ranges for each group. The significance level was set at a P value of .05. Journal of Allergy and Clinical Immunology 2008 122, 961-968DOI: (10.1016/j.jaci.2008.07.008) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Concentrations of soluble IL-2 receptor α (sIL-2Rα), IL-5, IFN-γ, IL-1β, IL-6, IL-17A, eotaxin, IgE, and TGF-β1 protein in each group. Values are reported as medians and interquartile ranges for each group. The significance level was set at a P value of .05. Please note that the TGF-β1 protein data refer to patients without asthma (see the Results section). Journal of Allergy and Clinical Immunology 2008 122, 961-968DOI: (10.1016/j.jaci.2008.07.008) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions